Company intelligence / Profile preview

Henan Wanxi Pharmaceutical

Ownership: Private
Development stage: Other

Overview

Henan Wanxi Pharmaceutical is one of China's largest producers of traditional Chinese medicine (TCM) concentrated pills and granules. The company has a strong commercial presence with nearly 100 herbal products on the market and ongoing clinical development for new TCM-based therapies such as Yinao Jieyu Granules in Phase 2 trials for depression.

Therapeutic areas: PsychiatryCardiovascularWomen's Health
Modalities: Small molecule (herbal extracts and traditional Chinese medicine concentrated pills)Herbal medicine
Industry: Biotech

Drug pipeline

1 asset

yougui wan

Beyond the preview

Go deeper on Henan Wanxi Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Henan Wanxi Pharmaceutical.

Explore the full profile